Standardizing care of those at great risk: the importance of sickle cell in pregnancy practice guidelines
- PMID: 34409588
- PMCID: PMC11396213
- DOI: 10.1111/bjh.17667
Standardizing care of those at great risk: the importance of sickle cell in pregnancy practice guidelines
Comment on
-
Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline.Br J Haematol. 2021 Sep;194(6):980-995. doi: 10.1111/bjh.17671. Epub 2021 Aug 19. Br J Haematol. 2021. PMID: 34409598 No abstract available.
References
-
- Chaturvedi S, DeBaun MR. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: the last 40 years. Am J Hematol. 2016;91(1):5–14. - PubMed
-
- Oteng-Ntim E, Meeks D, Seed PT, Webster L, Howard J, Doyle P, et al. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis. Blood. 2015;125(21):3316–25. - PubMed
-
- Inparaj S, Buckingham M, Oakley L, Seed PT, Lucas S, Oteng-Ntim E. Pulmonary complications for women with sickle cell disease in pregnancy: systematic review and meta-analysis. Thorax. 2020;75(7):568–75. - PubMed
-
- Boafor TK, Olayemi E, Galadanci N, Hayfron-Benjamin C, Dei-Adomakoh Y, Segbefia C, et al. Pregnancy outcomes in women with sickle-cell disease in low and high income countries: a systematic review and meta-analysis. BJOG. 2016;123(5):691–8. - PubMed
-
- Oteng-Ntim E, Pavord S, Howard R, Robinson S, Oakley L, Mackillop L, et al. Management of sickle cell disease in pregnancy. A British Society for Haematology Guideline. Br J Haematol. 2021. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
